The new division, which will be based out of CBLPath's headquarters in Rye Brook, NY, is licensed through New York State and will initially focus on hematologic cancers.
via Rye Brook Newswire http://ift.tt/1zNr0o8
via Rye Brook Newswire http://ift.tt/1zNr0o8
No comments:
Post a Comment